This is a preview of subscription content, access via your institution.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Cappelleri, J. C., Zou, K. H., Bushmakin, A. G., Alvir, J. M. J., Alemayehu, D., & Symonds, T. (2014). Patient-reported outcomes: Measurement, implementation and interpretation. Boca Raton: CRC Press.
Committee for Medicinal Products for Human Use (CHMP) (2005). Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf.
Food and Drug Administration (FDA) (2009). Guidance for industry on patient–reported outcome measures: Use in medical product development to support labelling claims. http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.
Patrick, D. L., Burke, L. B., Gwaltney, C. J., et al. (2011). Content validity—Establishing and reporting the evidence in newly-developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1—Eliciting concepts for a new PRO instrument. Value Health, 14, 967–977.
Reeve, R. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., et al. (2013). ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res, 22(8), 1889–1905.
About this article
Cite this article
Smith, A.B. Cappelleri JC, Zou KH, Bushmakin AG, Alvir JMJ, Alemayehu D, Symonds T: Patient-reported outcomes, measurement, implementation and interpretation. Qual Life Res 23, 2405–2406 (2014). https://doi.org/10.1007/s11136-014-0789-2